BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study

Reuters

2025/03/03

March 3 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O:

ACADIA PHARMACEUTICALS AND SANIONA ANNOUNCE INITIAL POSITIVE RESULTS FROM ACP-711 (FORMERLY SAN711) PHASE 1 STUDY
IN STUDY, ACP-711 WAS SAFE AND GENERALLY WELL TOLERATED ACROSS ALL DOSING COHORTS
THERE WERE NO SERIOUS ADVERSE EVENTS
NO SAFETY LABORATORY CONCERNS, CARDIOVASCULAR CONCERNS, OR ABNORMAL NEUROLOGICAL FINDINGS WERE OBSERVED

Source text: ID:nMFN6HH2Qx

Further company coverage: ACAD.O

(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2516042631"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2516042631\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2516042631?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-03 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516042631","market":"nz","top_or_hot":-1,"title":"BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>ACADIA Pharmaceuticals Inc <span>ACAD.O</span>:</p><ul><li><p>ACADIA PHARMACEUTICALS AND SANIONA ANNOUNCE INITIAL POSITIVE RESULTS FROM ACP-711 (FORMERLY SAN711) PHASE 1 STUDY</p></li><li><p>IN STUDY, ACP-711 WAS SAFE AND GENERALLY WELL TOLERATED ACROSS ALL DOSING COHORTS</p></li><li><p>THERE WERE NO SERIOUS ADVERSE EVENTS</p></li><li><p>NO SAFETY LABORATORY CONCERNS, CARDIOVASCULAR CONCERNS, OR ABNORMAL NEUROLOGICAL FINDINGS WERE OBSERVED</p></li></ul><p>Source text: <span>ID:nMFN6HH2Qx</span></p><p>Further company coverage: <span>ACAD.O</span></p><p> (Gdansk Newsroom)</p><p> ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-03 22:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 Study</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>ACADIA Pharmaceuticals Inc <span>ACAD.O</span>:</p><ul><li><p>ACADIA PHARMACEUTICALS AND SANIONA ANNOUNCE INITIAL POSITIVE RESULTS FROM ACP-711 (FORMERLY SAN711) PHASE 1 STUDY</p></li><li><p>IN STUDY, ACP-711 WAS SAFE AND GENERALLY WELL TOLERATED ACROSS ALL DOSING COHORTS</p></li><li><p>THERE WERE NO SERIOUS ADVERSE EVENTS</p></li><li><p>NO SAFETY LABORATORY CONCERNS, CARDIOVASCULAR CONCERNS, OR ABNORMAL NEUROLOGICAL FINDINGS WERE OBSERVED</p></li></ul><p>Source text: <span>ID:nMFN6HH2Qx</span></p><p>Further company coverage: <span>ACAD.O</span></p><p> (Gdansk Newsroom)</p><p> ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065169927.USD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM10R:1","article_id":"2516042631","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516042631","pubTimestamp":1741012412,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 StudyMarch 3 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O:ACADIA PHARMACEUTICALS AND SANIONA ANNOUNCE INITIAL POSITIVE RES","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4139":"生物科技","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","ACAD":"阿卡迪亚"},"translate_title":"简介-Saniona和Acadia宣布ACP-711 1期研究的初步积极结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACAD":0.9},"content_text":"BRIEF-Saniona, Acadia Announce Initial Positive Results From ACP-711 Phase 1 StudyMarch 3 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O:ACADIA PHARMACEUTICALS AND SANIONA ANNOUNCE INITIAL POSITIVE RESULTS FROM ACP-711 (FORMERLY SAN711) PHASE 1 STUDYIN STUDY, ACP-711 WAS SAFE AND GENERALLY WELL TOLERATED ACROSS ALL DOSING COHORTSTHERE WERE NO SERIOUS ADVERSE EVENTSNO SAFETY LABORATORY CONCERNS, CARDIOVASCULAR CONCERNS, OR ABNORMAL NEUROLOGICAL FINDINGS WERE OBSERVEDSource text: ID:nMFN6HH2QxFurther company coverage: ACAD.O (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}